price month
 close
ep ahead consensu abax ep
exceed estim better revenu slightli higher
profit factor line ad maintain
ep estim reflect dd top-line growth increment
invest salesforc
revenu buoy new products/stock revenu growth
ex fx ahead conserv estim
stronger veterinari experi vs estimate half growth
attribut new product vetscan sa associ stock
vetscan placement well plan despit easi comp
place vetscan sa ww vet rotor sale similarli plan
vs estimate weaker rotor volum vs estimate
 america human medic plan
declin piccolo unit gross margin fell bp oper
expens rose bp anticip invest sale forc
result ebit margin degrad bp bp view
reserv strong million
share may ebb abax share ytd vs flat
view share move lower oper line quarter
monument chang model innov initi repres
necessari new growth opportun half top-line growth attribut
new product associ stock competit placement
core vetscan unit declin america associ vet rotor sale
rise seemingli disconnect faster broader industri demand
still high-level guidanc call dd revenu growth partial off-set
continu sale forc invest expect hire sale
rep share trade ep meaning
premium anim health peer maintain under-perform rate
valuat metric
number share
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
abax lead manufactur point-of-car diagnost
equip particip anim human health care
set develop portabl blood instrument rapidli measur
blood constitu clinician offic set
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
cash-flow financ activ
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
gain veterinari substanti acceler human medic
placement significantli improv relationship vendor
partner rapid traction/launch new pipelin
grey sky valuat assum increasingli
continu difficulti distribut relationship meaning
contribut new product launch unexpect weak
broader industri demand
 close
investor focu veterinari segment consum vs estimate
instrument sale vs estimate benefit rapid assay demand
partial due shift hybrid direct sale model dynam
appar veterinari consum post growth help
stock associ new rapid test drive bulk sub-seg
upsid veterinari consum rotor sale weaker expect estimate
heel growth strike disconnect broader industri demand
america american competit placement also fell yoy unit
medic sale plan increas vs estimate piccolo volum
declin quarter manag attribut short-term hesit
purchas physician marketplac caus challeng reimburs
profit deterior yoy due anticip step invest sale forc
 ebit margin declin bp yoy bp view
relev data point quarter summar
competit account
competit account
note report result may
veterinari revenu
veterinari sale increas well estim despit core chemistri
vetscan placement declin declin core vetscan placement
off-set rapid assay strength placement vetscan
sa vetscan placement competit account america deterior
total unit place consum disc util well plan
note estim yoy increas rotor asp help boost consum
revenu million yoy
vetscan instrument placement unit
medic revenu
human medic revenu growth plan manag
attribut difficult reimburs environ human medic retail
opportun remain somewhat elus substant updat on-going pilot
program still repres sizeabl opportun view
view competit across dognost space subsid consist
industri survey work suggest potenti upsid ahead ep
report next week may howev abax make dilig effort catch
innov standpoint particularli note traction penetr
us thu far
abax debut three new product februari vmx confer see report
confer vmx takeaway review earli commentari today call
product
manag note broader respons relat
fantast complaint distributor end user although sale figur
disclos manag note vast major million growth
veterinari consum came sale remind
later flow test use detect heartworm diseas
lyme diseas ehrlichiosi anaplasmosi canin util two drop whole
blood compet directli competitor idexx laboratori snap
popular analyz recent veterinari survey
vetscan sa abax sold unit quarter character custom
respons fantast well report veterinarian increas number
urin test perform due eas use note manag state
vetscan sa connect vetscan urin analyz end
anticip connect analyz fuse system point
remind vetscan sa sediment analyz compet directli
alin analyz manag note next gener i-stat alin
launch middl compani aim establish connect
alin fuse ecosystem point alin
product includ hardwar softwar upgrad previou version i-
stat potenti expand test menu
earn outlook valuat
earn forecast call revenu increas million
acceler benefit launch new product partial off-set
cost associ ramp salesforc invest
forecast ep grow bp ebit margin expans
driven greater revenu trajectori
forecast ep growth revenu growth
million continu challeng competit environ forecast
predic approxim bp ebitda margin expans
abax share current trade ep premium peer group
anim health compani suggest upsid potenti stock may limit
pt impli multipl ep estim ev/ebitda multipl
discount histor averag multipl respect
reflect slow growth trajectori
compani mention price
